The Biomedical Advanced Research and Development Authority awarded Cellerant Therapeutics a $36.4 million grant to help further develop CLT-008, an allogeneic stem cell-based treatment for acute radiation syndrome. The funding is part of a five-year grant that could total $169.9 million. Cellerant will put the money toward ongoing clinical and nonclinical studies, as well as process development and manufacturing.
Cellerant gets $36.4M for stem cell-based radiation syndrome therapy
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|